» Articles » PMID: 22734110

The Pathogenic Role of the Renal Proximal Tubular Cell in Diabetic Nephropathy

Overview
Date 2012 Jun 27
PMID 22734110
Citations 96
Authors
Affiliations
Soon will be listed here.
Abstract

A growing body of evidence indicates that the renal proximal tubular epithelial cell (PTEC) plays an important role in the pathogenesis of diabetic nephropathy (DN). Microalbuminuria that intensifies over time to overt proteinuria, a hallmark of DN, is already known to activate the PTEC to induce tubulointerstitial inflammation. In addition to proteins, a number of diabetic substrates including high glucose per se, advanced glycation end-products and their carbonyl intermediates, angiotensin II, and ultrafiltered growth factors activate a number of signaling pathways including nuclear factor kappa B, protein kinase C, extracellular signal-regulated kinase 1/2, p38, signal transducer and activator of transcription-1 and the generation of reactive oxygen species, to culminate in tubular cell hypertrophy and the accumulation in the interstitium of a repertoire of chemokines, cytokines, growth factors and adhesion molecules capable of orchestrating further inflammation and fibrosis. More recently, the kallikrein-kinin system (KKS) and toll-like receptors (TLRs) in PTECs have been implicated in this process. While in vitro data suggest that the KKS contributes to the progression of DN, there are conflicting in vivo results on its precise role, which may in part be strain-dependent. On the other hand, there are both in vitro and in vivo data to suggest a role for both TLR2 and TLR4 in DN. In this review, we offer a critical appraisal of the events linking the participation of the PTEC to the pathogenesis of DN, which we believe may be collectively termed diabetic tubulopathy.

Citing Articles

Proximal tubule hypertrophy and hyperfunction: a novel pathophysiological feature in disease states.

Kanbay M, Copur S, Guldan M, Ozbek L, Hatipoglu A, Covic A Clin Kidney J. 2024; 17(7):sfae195.

PMID: 39050867 PMC: 11267238. DOI: 10.1093/ckj/sfae195.


Tonabersat suppresses priming/activation of the NOD-like receptor protein-3 (NLRP3) inflammasome and decreases renal tubular epithelial-to-macrophage crosstalk in a model of diabetic kidney disease.

Cliff C, Squires P, Hills C Cell Commun Signal. 2024; 22(1):351.

PMID: 38970061 PMC: 11225428. DOI: 10.1186/s12964-024-01728-1.


Astragaloside IV attenuates renal tubule injury in DKD rats via suppression of CD36-mediated NLRP3 inflammasome activation.

Li X, Dong X, Zhang L, Zhang S, Huang W, Wang C Front Pharmacol. 2024; 15:1285797.

PMID: 38572426 PMC: 10987761. DOI: 10.3389/fphar.2024.1285797.


High CD133 expression in proximal tubular cells in diabetic kidney disease: good or bad?.

Zhang Y, Xu L, Guo C, Li X, Tian Y, Liao L J Transl Med. 2024; 22(1):159.

PMID: 38365731 PMC: 10870558. DOI: 10.1186/s12967-024-04950-0.


Renal protective effect of ellipticine against streptozotocin induced diabetic nephropathy in rats via suppression of oxidative stress and inflammatory mediator.

Li J, Xie Y, Sun J, Bai F, Althaf Hussain S, Gangireddygari V Acta Cir Bras. 2023; 38:e385623.

PMID: 38055383 PMC: 10695187. DOI: 10.1590/acb385623.